Target intelligence / Profile preview

Caseinolytic protease P subunit 2 (ClpP2)

Target
ClpP2
Molecular classification
Enzyme, Serine protease, ATP-dependent protease
01

Overview

Caseinolytic protease P subunit 2 (ClpP2) is a component of the bacterial Clp protease complex, a major ATP-dependent serine protease that ensures protein quality control, stress tolerance, and turnover of regulatory proteins[1][2][3][7]. Structurally, ClpP2 forms part of a barrel-like tetradecamer (14 subunits, often in conjunction with ClpP1) that degrades misfolded, damaged, or regulatory proteins that are translocated into its proteolytic chamber by AAA+ ATPase chaperones such as ClpX or ClpC[1][5][7]. In several pathogenic bacteria (e.g., Mycobacterium tuberculosis, Listeria monocytogenes, Leptospira interrogans, Chlamydia trachomatis), ClpP2 is indispensable for growth, virulence, and adaptation to stress[3][4][6][7]. ClpP2 has emerged as a promising antibiotic target: chemical activators (including ADEPs and certain peptidomimetic boronates) dysregulate the protease, leading to lethal degradation of essential bacterial proteins, while inhibitors can block its proteolytic function[5][3].

Other names
ClpP2Clp protease subunit P2ClpP-2ClpP II
02

Mechanism of action

Small-molecule activators (such as ADEPs or Bz-LL) dysregulate or hyperactivate ClpP2, resulting in uncontrolled proteolysis and bacterial death; inhibitors bind active sites to block proteolysis

03

Biological functions

Protein degradationProtein quality controlCellular homeostasisStress responseVirulence regulation
04

Disease associations

InfectionAntibacterial target
05

Safety considerations

Possible off-target effects if drugs cross-react with mitochondrial/host ClpPessentiality in bacteria raises concern for rapid development of resistancespecificity for bacterial ClpP variations required for therapeutic targeting
06

Interacting drugs

Acyldepsipeptides (ADEPs)

2 more in the full profile.

Beyond the preview

Go deeper on Caseinolytic protease P subunit 2 (ClpP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caseinolytic protease P subunit 2 (ClpP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call